Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
Incyte(INCY) stock is priced at $93.09, giving the company a market capitalization of 18.51B. It carries a P/E multiple of 14.51.
Incyte(INCY) stock opened on 2026-03-17 at $92.17. The price climbed to — and dipped to —.
Incyte(INCY) shares are trading with a volume of 0, against a daily average of 1.59M.
During the past year, Incyte(INCY) stock moved between $53.56 at its lowest and $112.29 at its peak.
During the past year, Incyte(INCY) stock moved between $53.56 at its lowest and $112.29 at its peak.
INCY News
In early March 2026, Incyte reported a U.S. FDA Complete Response Letter for an additional lung cancer indication of Zynyz due to compliance issues at a third‑p...
Jefferies analyst Faisal Khurshid downgraded Incyte (INCY) to Hold from Buy with a price target of $94, down from $120, after assuming coverage of the name. The...
Incyte (INCY) announced an update on their ongoing clinical study. Incyte Corp. has launched a Phase 1 study called “A Study to Evaluate the Pharmacokinetics,...
Analyst ratings
50%
of 28 ratingsMore INCY News
Incyte (INCY) announced an update on their ongoing clinical study. Incyte Inc. (INCY) has updated a Phase 2 study called “A Phase 2 Study of the JAK1/JAK2 Inhi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.